| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Omenn Gilbert S is a Director at AMST, with reported holdings spanning 4 companies. Recent filings cover 7 purchases and 2 sales. Those positions are worth an estimated $519K at current prices.
Our model assigns Omenn Gilbert S a below-average insider score of 17/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -60.6%.
Omenn Gilbert S's largest disclosed position is in GALT as Director, worth about $230K. The recent filings there lean toward selling, a net 792 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | AMST Amesite Inc. | Director | Buy | 3,333 | $3.00 | $9,999.00 | +51.5% | -21.8% | -28.2% | |
| Dec 14, 2021 | AMST Amesite Inc. | Director | Buy | 16,000 | $1.18 | $18,824.80 | +12.2% | -54.7% | -77.4% | |
| Sep 29, 2020 | AMST Amesite Inc. | Director | Buy | 20,000 | $5.00 | $100,000.00 | +48.0% | - | - | |
| May 31, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 18,578 | $4.28 | $79,513.84 | +38.6% | - | - | |
| Sep 10, 2018 | GALT Galectin Therapeutics Inc | Director | Sell | 19,370 | $6.02 | $116,585.20 | -15.6% | - | - | |
| Mar 21, 2017 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 1,000 | $42.26 | $42,260.00 | New | - | - | |
| Mar 1, 2016 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 5,000 | $15.28 | $76,400.00 | +100.0% | - | - |